LifeCannMD

OCTOBER 30, 2020

Cannabis Terpenes are not only the cause of the plant’s fragrance and color, but they also work with cannabinoids to elicit specific types of effects to be used in treatment. If a patient isn’t choosing their Medical Marijuana by the Terpenes they include, they might not be getting the optimum effect to treat their condition.

Terpenes 52

Terpenes Strains Chronic Pain Patients 52

Green Relief

FEBRUARY 19, 2018

Over the years of helping clients optimize their health through nutrigenomics, I’ve seen some amazing results including successful weaning off harmful pharmaceuticals, and reversals of difficult to treat conditions (ie: cancer, autoimmune). Piomeli, Daniele (2002). 2002 Feb-Mar;66(2-3):143-60. Watters, E.(2008) DiMarzo, V.,

Therapy 40

Therapy Cannabinoids Terpenes Pharmaceutical 40

Green Relief

FEBRUARY 20, 2018

Over the years of helping clients optimize their health through nutrigenomics, I’ve seen some amazing results including successful weaning off harmful pharmaceuticals, and reversals of difficult to treat conditions (ie: cancer, autoimmune). Piomeli, Daniele (2002). 2002 Feb-Mar;66(2-3):143-60. Watters, E.(2008) DiMarzo, V.,

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Alchimia

JUNE 20, 2016

The exact CBD dosage still remains undefined by the science and greatly varies depending on the disease to treat; most treatments start with a dose of 1mg CBD per Kg of bodyweight, which is gradually increased if necessary. CBD and neurological conditions. Normally, CBD products can be purchased as CBD oils, capsules or sprays.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming. Are psychedelics safe?

History 123

History Microdosing Research and Development Clinical Trials 123

Green Relief

MAY 13, 2018

Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. Complementary Therapies for TBI. Terpenes.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

JUNE 24, 2021

9-THC, the main psychoactive component in cannabis, rose from about 4 per cent to 16 per cent in the United States over the period 1995–2019, and from about 6 per cent to 11 per cent in Europe over the period 2002–2019. ?9-THC Drug Use Rising, but Science-Based Treatment More Available. According to the Report, the percentage of ?9-THC

Research and Development 99

Research and Development Supply Chain Pharmaceutical Treatment 99

Cannabis Law Report

JULY 12, 2019

Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Fabricio A.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Green Relief

MAY 12, 2018

Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. Complementary Therapies for TBI. Terpenes.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. where patients are legally administered ketamine for treatment of mental illness and severe pain.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JULY 28, 2021

Dr. Greenshaw is a Fellow of the Royal Society of Arts; a Fellow of the Canadian College of Neuropsychopharmacology (CCNP), for which he served as President from 2000-2002; and a fellow of the Collegium Internationale Neuropsychopharmacologicum (CINP). “We would like to extend a warm welcome to Andy as he joins the team at Entheon.

Research and Development 105

Research and Development Events Media Data 105

The Cannigma

JANUARY 3, 2023

Dr. Ethan Russo, a renowned cannabis scientist, published a paper in 2002 detailing historical uses of cannabis in women’s health. A 2016 study examined endocannabinoid levels in women with and without endometriosis, a condition that causes painful periods due to growth on the outside of the uterus.

Terpenes 110

Terpenes Strains Oil THC 110

SpeedWeed

FEBRUARY 21, 2021

His show “So You Wanna Grow Pot” was launched in 2002, and taught thousands of people how to grow marijuana properly. Always the strong, silent and brave soul, he didn’t want to add any worries to anyone else’s burdens, so he kept quiet about his condition.

Marijuana 52

Marijuana Events Access Medicine 52

Cannabis Law Report

NOVEMBER 16, 2019

Globally, there is a never-ending cascade of information and research extolling the use of cannabis and its derivatives as a medical treatment for various illnesses and conditions.

Banking 45

Banking Legalization Research and Development Cannabis 45

Medical Cannabis Seedbank

AUGUST 6, 2018

They have noted the Cannabis plant as a great option for a number of conditions. The purpose of the ICCI is to enable the scientific examination of cannabis compounds and their relation and interaction on the human body in the treatment of specific ailments. 4) Spain- senior researchers.

Research and Development 61

Research and Development Cultivation Chronic Pain Cannabis 61

SpeedWeed

FEBRUARY 19, 2021

Nunn, 2002). They retted the stems and twisted the fibers into sturdy ropes and ground the plant to make a soothing eyewash, a treatment they recorded in the medical papyri. The Berlin Papyrus (1300 BC) records a topical treatment for swelling: “A remedy to treat inflammation: “Blätter (oder Blüten?) Gebrauch es als Salbe.”

Research and Development 52

Research and Development Cannabis Hemp Concentrates 52

Cannabis Law Report

JANUARY 21, 2019

The California treatment of pension income is generally the same as federal treatment. This act runs from 2008 through 2012 and reauthorizes most programs of the 2002 farm bill. b) All required records shall be prepared and retained in accordance with the following conditions: Records shall be legible; and. . (2)

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40